All terms in MeSH

Label Id Description
Eye Diseases, Hereditary D015785 [Transmission of gene defects or chromosomal aberrations/abnormalities which are expressed in extreme variation in the structure or function of the eye. These may be evident at birth, but may be manifested later with progression of the disorder. ]
Cytochromes b5 D015786 [Cytochromes of the b group that are found bound to cytoplasmic side of ENDOPLASMIC RETICULUM. They serve as electron carrier proteins for a variety of membrane-bound OXYGENASES. They are reduced by the enzyme CYTOCHROME-B(5) REDUCTASE. ]
Pain Threshold F02.830.816.444.700
Pain F02.830.816.444
Bacterial Toxins D23.946.123
Arterio-Arterial Fistula D001159 [Abnormal communication between two ARTERIES that may result from injury or occur as a congenital abnormality. ]
Substance Abuse Treatment Centers N02.278.035.128.800
Community Health Centers N02.278.035.128
Ancillary Services, Hospital N02.278.216.500.500
NF-kappa B p50 Subunit D12.776.260.600.124
Arsphenamine D001153 [An organoarsenic compound that was commonly used for treating SYPHILIS and other diseases. ]
Aphasia, Conduction C10.597.606.150.500.800.100.111
Myosin Type IV D025121 [A subclass of myosin found in ACANTHAMOEBA. It is a non-filamentous myosin containing a single 180-kDa myosin heavy chain. ]
Art D001154 [Processes and results of aesthetic expression. ]
Melanesia Z01.639.760.590
Arsenic D001151 [A shiny gray element with atomic symbol As, atomic number 33, and atomic weight 75. It occurs throughout the universe, mostly in the form of metallic arsenides. Most forms are toxic. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), arsenic and certain arsenic compounds have been listed as known carcinogens. (From Merck Index, 11th ed) ]
Trophoblastic Tumor, Placental Site C04.850.908.208.875
Choriocarcinoma C04.850.908.208
Arsenicals D001152 [Inorganic or organic compounds that contain arsenic. ]
HLA-DQ Antigens D12.776.543.550.440.400.430